![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Assessing PrEP Needs Among Heterosexuals and People Who Inject Drugs, Washington, DC
|
|
|
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
Irene Kuo,1Anya Agopian,1Jenevieve Opoku,2Anthony Rawls,1Rudy Patrick,3Manya Magnus,1Michael Kharfen,2Alan Greenberg1
1 Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, George Washington University; 2 The HIV/AIDS, Hepatitis, STD, and Tuberculosis Administration, DC Department of Health; 3 Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego
![AASDL1](../images%20/040518/040418-12/AASDL1.gif)
![AASDL2](../images%20/040518/040418-12/AASDL2.gif)
1 U.S. Public Health Service. PreexposureProphylaxis for the Prevention of HIV Infection in the United States -2014. https://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf 2 Kelley CF, KahleE, SieglerA, et al. Applying a PrEPContinuum of Care for Men Who Have Sex With Men in Atlanta, Georgia. ClinInfect Dis. 2015;61(10):1590-7.
3 Levy M, Magnus M, Siegel M, et al. An Evaluation of the PrEPCare Continuum among Men who Have Sex with Men Aged 16-25 in Washington, DC. AIDS Research and Human Retroviruses. 2016;32:248. ISSN: 08892229.
![AASDL3](../images%20/040518/040418-12/AASDL3.gif)
![AASDL4](../images%20/040518/040418-12/AASDL4.gif)
![AASDL5](../images%20/040518/040418-12/AASDL5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|